202
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Design and Click Synthesis of Novel 1- Substituted-4-(3,4-Dimethoxyphenyl)-1H-1,2,3-Triazole Hybrids for Anticancer Evaluation and Molecular Docking

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 7547-7564 | Received 24 Aug 2022, Accepted 12 Oct 2022, Published online: 27 Oct 2022
 

Abstract

In an attempt to improve the performance of biologically active anticancer agents, a novel series of 1-substituent-4-(3,4-dimethoxyphenyl)-1H-1,2,3-triazole hybrids 10–16 were designed and efficiently synthesized via the copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reactions of 4-ethynyl-1,2-dimethoxybenzene 1 with substituted-azides 2–8. The structure of the new clicked 1,2,3-triazole hybrids 10–16 was confirmed on the basis of their elemental analysis and spectral data. Moreover, the cytotoxicity and in vitro anticancer activities of the newly synthesized compounds were also assessed against four different human cancer cell lines: Colon cancer (HCT116), Hepatocellular carcinoma (Hep G2), Breast cancer (MCF-7), and Lung carcinoma (A549). Among all the tested compounds, compound 15 revealed a higher potency against HCT116 compared to the activity of the reference drug, doxorubicin. This makes it an interesting candidate for further biological evaluation. Finally, a good correlation was obtained between the observed cytotoxicity evaluation of compound 15 against HCT116, from one side, and the molecular descriptors from another side.

Graphical Abstract

Acknowledgments

The authors would like to extend their sincere appreciation to the National Research Centre and Egyptian Atomic Energy Authority.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Author contributions

T. El Malah Conducting experiments, execution, methodology, conceptualization, analysis of compounds, and writing the original draft. H. Farag: Conducting experiments, methodology, and editing. H.M. Awad: Conducting anticancer analyses, writing biological section, and editing. M.T. Abdelrahman: Conducting molecular docking, writing docking section, and editing. A.H. Shamroukh: Data curation, reviewing, and editing. All authors have participated in the editing, revision and agreed to the published version of the manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.